Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMALVY, Denis
dc.contributor.authorGAUZERE, B A
dc.contributor.authorMIGLIANI, R
dc.date.accessioned2020-06-29T08:45:28Z
dc.date.available2020-06-29T08:45:28Z
dc.date.issued2019-12
dc.identifier.issn2213-0276 (Electronic) 0755-4982 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/8258
dc.description.abstractEnAfrica along side with south-east Asia are the epicentres of emerging and epidemic prone-infectious diseases and megacity biosecurity threat scenarios. Massive mobility and reluctance in the populations exposed to epidemic and emerging prone-infectious diseases coupled by a weak health system made disease alert and control measures difficult to implement. The investigation of virus detection and persistence in semen across a range of emerging viruses is useful for clinical and public health reasons, in particular for viruses that lead to high mortality or morbidity rates or to epidemics. Innovating built facility to safely treat patients with highly pathogenic infectious diseases is urgently need, not only to prevent the spread of infection from patients to healthcare workers but also to offer provision of relatively invasive organ support, whenever considered appropriate, without posing additional risk to staff. Despite multiple challenges, the need to conduct research during epidemics is inevitable, and candidate products must continue undergoing rigorous trials. Preparedness including management of complex humanitarian crises with community distrust is a cornerstone in response to high consequence emerging infectious disease outbreaks and imposes strengthening of the public health response infrastructure and emergency outbreak systems in high-risk regions.
dc.language.isoFRen_US
dc.subject.enIDLIC
dc.titleQu'apprend-t-on de nouveau des épidémies émergentes ?
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.lpm.2019.09.036en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31784255en_US
bordeaux.journalLa Presse Médicaleen_US
bordeaux.page1536-1550en_US
bordeaux.volume48en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue12en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03212407
hal.version1
hal.date.transferred2021-04-29T13:33:50Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.title=Qu'apprend-t-on%20de%20nouveau%20des%20%C3%A9pid%C3%A9mies%20%C3%A9mergentes%20?&rft.atitle=Qu'apprend-t-on%20de%20nouveau%20des%20%C3%A9pid%C3%A9mies%20%C3%A9mergentes%20?&rft.jtitle=La%20Presse%20M%C3%A9dicale&rft.date=2019-12&rft.volume=48&rft.issue=12&rft.spage=1536-1550&rft.epage=1536-1550&rft.eissn=2213-0276%20(Electronic)%200755-4982%20(Linking)&rft.issn=2213-0276%20(Electronic)%200755-4982%20(Linking)&rft.au=MALVY,%20Denis&GAUZERE,%20B%20A&MIGLIANI,%20R&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée